Table 2 Characteristics in the BAD and LD groups in the two different territories.
LSA | P-value | APA | P-value | |||
|---|---|---|---|---|---|---|
BAD (n = 37) | LD (n = 99) | BAD (n = 69) | LD (n = 16) | |||
Age (years) | 64 ± 13 | 67 ± 11 | 0.152 | 68 ± 11 | 63 ± 8 | 0.051 |
Male | 17 (45.9) | 49 (49.5) | 0.712 | 40 (58) | 9 (56.3) | 0.9 |
Hypertension | 26 (70.3) | 78 (78.8) | 0.297 | 54 (78.3) | 8 (50) | 0.022 |
Diabetes mellitus | 12 (32.4) | 24 (24.2) | 0.335 | 29 (42) | 5 (31.3) | 0.428 |
Hyperlipidemia | 26 (70.3) | 45 (45.5) | 0.01 | 35 (50.7) | 7 (43.8) | 0.615 |
Smoking history | 15 (40.5) | 29 (29.3) | 0.212 | 28 (40.6) | 10 (62.5) | 0.112 |
Previous stroke history | 9 (24.3) | 25 (25.3) | 0.911 | 18 (26.1) | 5 (31.3) | 0.675 |
Previous antiplatelet | 2 (5.4) | 15 (15.2) | 0.126 | 10 (14.5) | 0 | 0.105 |
Previous statin | 1 (2.7) | 14 (14.1) | 0.058 | 6 (8.7) | 2 (12.5) | 0.639 |
Initial NIHSS (IQR) | 4 (2–6) | 3 (1–5) | 0.035 | 4 (2–5) | 1 (0–3) | 0.001 |
White matter hyperintensities | 0.014 | 0.186 | ||||
0 | 10 (27) | 8 (8.1) | 6 (8.7) | 4 (25) | ||
1 | 19 (51.4) | 49 (49.5) | 43 (62.3) | 7 (43.8) | ||
2 | 6 (16.2) | 29 (29.3) | 13 (18.8) | 2 (12.5) | ||
3 | 2 (5.4) | 13 (13.1) | 7 (10.1) | 3 (18.8) | ||
Microbleeds | 7 (18.9) | 35 (35.4) | 0.065 | 20 (29) | 6 (37.5) | 0.505 |
Lacunes | 11 (29.7) | 47 (47.5) | 0.063 | 59 (37.7) | 6 (37.5) | 0.989 |
Stenosis degree | 0.795 | 0.017 | ||||
No stenosis | 27 (73) | 70 (70.7) | 29 (40.6) | 12 (68.8) | ||
< 50% stenosis | 10 (27) | 29 (29.3) | 40 (59.4) | 4 (31.3) | ||
MCA or BA shape | 0.026 | 0.281 | ||||
Straight | 14 (37.8) | 32 (32.3) | 30 (43.5) | 4(25) | ||
U or C shape | 12 (32.4) | 15 (15.2) | 33 (47.8) | 9 (56.3) | ||
S shape | 11 (29.7) | 52 (52.5) | 6 (8.7) | 3 (18.8) | ||
